2018 annual financial data
Inhibikase Therapeutics 2018 Net margin
Direct answer
Net margin was -53.27%.
Operating income was -2,122,121 USD and net income was -2,152,453 USD.
Operating cash flow was 714,987 USD.
Get free Inhibikase Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,040,955 USD
- Operating income
- -2,122,121 USD
- Net income
- -2,152,453 USD
- Operating cash flow
- 714,987 USD
Explore related company data
View all 2018 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Inhibikase Therapeutics financial years